FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
05/23/2023
Back to search
Official data from USPTO
OXYCARE
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
OXYCARE
ST13
US500000079325960Class
5, 10, 11, 12, 44
Filing
79325960
Registration
6926933
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
34
Latest update
05/23/2023
Trademark type
Word
Nice classes
5, 10, 11, 12, 44
Filing date
06/03/2021
Registration date
12/20/2022
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
12/20/2022
Last transaction
12/20/2022
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
4
Owner type
27
Owner location
DE
Examiner
VAGHANI, MAYUR
Law office
N60
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
OXYCARE GmbH Sauerstoff.Beatmungstechnik
Representatives
Laurence P. Colton SMITH TEMPEL BLAHA LLC
Technical classification
Nice Classes
Class 5Class 10Class 11Class 12Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Plasters; dressings for wounds and burns; adhesive tapes for medical purposes
Class 10
Medical apparatus and instrumentsin particular stationary and mobile oxygen concentrators for medical purposesartificial heart-lung oxygen apparatus for medical purposesventilators for medical purposesoxygen masks for medical purposesoxygen sensors for medical purposesoxygen electrodes for medical purposesoxygen inhalers for medical purposesoxygen inhalators for therapeutic purposesoxygen concentrators for medical applicationsoxygen monitoring apparatusoxygen concentration analysis and oxygen concentration monitoring apparatus for medical purposesunfilled oxygen inhalers for medical purposesoxygen generating apparatus for medical purposesmedical apparatus for measuring the oxygen content of bloodportable instruments for medical purposes for monitoring the oxygen content in gas mixtures; biomechanical stimulation devices for nervesskin and muscles for medical and rehabilitation purposes; high oxygen concentration masks for medical purposes for cluster headacheultrasonic nebulisers for medical purposescapnographs for medical purposespulse oximeters for medical purposesfinger pulse oximeters for medical purposessecretion aspirators in the nature of manual sputum aspirators and nasal aspirators; apparatusappliancesinstruments and machines for physical exercise for therapeutic or medical purposes; mobility aids for the disabledwalking aidswalking frameswheeled walking framesrolling walkers; physical training apparatus for rehabilitationmedical and therapeutic purposes
Class 11
Air purifiers
Class 12
Land transport equipmentin particular mobility aids for disabled personswheelchairs
Class 44
Medical services; health and beauty care for humans; medical care; hospital services; medical equipment rental; consultancy and information in the medical field; services for the preparation of diagnostic medical reports; preparation of diagnostic reports relating to medical matters
Publications
History of USPTO decisions and trademark events.
34 publications found
XXSS
GENERIC MADRID TRANSACTION SENT TO IB
04/05/2023
XXCR
GENERIC MADRID TRANSACTION CREATED
04/04/2023
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
03/20/2023
LIMN
LIMITATION FROM THE IB EXAMINED, NO ACTION IS NEEDED
01/03/2023
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
12/20/2022
R.PR
REGISTERED-PRINCIPAL REGISTER
12/20/2022
LIMG
LIMITATION OF GOODS RECEIVED FROM IB
10/30/2022
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
10/04/2022
PUBO
PUBLISHED FOR OPPOSITION
10/04/2022
GPNX
NOTIFICATION PROCESSED BY IB
10/03/2022
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
09/14/2022
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
09/14/2022
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
09/14/2022
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
09/01/2022
XAEC
EXAMINER'S AMENDMENT ENTERED
09/01/2022
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
09/01/2022
GNEA
EXAMINERS AMENDMENT E-MAILED
09/01/2022
CNEA
EXAMINERS AMENDMENT -WRITTEN
09/01/2022
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
09/01/2022
GNFR
FINAL REFUSAL E-MAILED
09/01/2022
CNFR
FINAL REFUSAL WRITTEN
09/01/2022
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
08/04/2022
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
08/03/2022
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
08/03/2022
RFNT
REFUSAL PROCESSED BY IB
04/18/2022
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
03/29/2022
RFRR
REFUSAL PROCESSED BY MPU
03/29/2022
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
02/26/2022
CNRT
NON-FINAL ACTION WRITTEN
02/25/2022
DOCK
ASSIGNED TO EXAMINER
02/18/2022
MAFR
APPLICATION FILING RECEIPT MAILED
11/23/2021
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
11/19/2021
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
11/18/2021
Continuous trademark protection
Get notified about every new filing that threatens OXYCARE or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.